Phase I trial and pharmacokinetics of gemcitabine in children with advanced solid tumors.
about
Mechanistic studies of Gemcitabine-loaded nanoplatforms in resistant pancreatic cancer cells.Gemcitabine and docetaxel (GEMDOX) for the treatment of relapsed and refractory pediatric sarcomas.Synergetic anticancer effect of combined gemcitabine and photodynamic therapy on pancreatic cancer in vivoChitosan and glyceryl monooleate nanostructures containing gemcitabine: potential delivery system for pancreatic cancer treatment.In vitro and in vivo anti-tumor activities of a gemcitabine derivative carried by nanoparticles.Modular polymer-caged nanobins as a theranostic platform with enhanced magnetic resonance relaxivity and pH-responsive drug release.Folate-chitosan-gemcitabine core-shell nanoparticles targeted to pancreatic cancerPemetrexed and gemcitabine as combination therapy for the treatment of Group3 medulloblastoma.Stearoyl gemcitabine nanoparticles overcome resistance related to the over-expression of ribonucleotide reductase subunit M1.New drugs for the treatment of metastatic or refractory soft tissue sarcomas in children.Phase I and Phase II Objective Response Rates are Correlated in Pediatric Cancer Trials: An Argument for Better Clinical Trial EfficiencyHistone deacetylase inhibitors in lymphoma and solid malignancies.Gemcitabine-loaded innovative nanocarriers vs GEMZAR: biodistribution, pharmacokinetic features and in vivo antitumor activity.A comparison of safety and efficacy of cytotoxic versus molecularly targeted drugs in pediatric phase I solid tumor oncology trials.Gemcitabine induced skin rash.Establishing A Preclinical Multidisciplinary Board for Brain Tumors.Biodistribution of Self-Assembling Polymer-Gemcitabine Conjugate after Systemic Administration into Orthotopic Pancreatic Tumor Bearing Mice.A novel anticancer theranostic pro-prodrug based on hypoxia and photo sequential control.
P2860
Q31098128-AFBD68DB-FBAA-4CA1-9368-2832FF7C38F3Q33399473-C4484D2B-AD78-4DCA-9AD8-F0EC9A251CFBQ33409922-746C655B-AE46-421C-8532-7502E312C116Q33773101-D96BC640-0306-4358-9C0C-5A3F765FF964Q34819537-0AE29CC6-DA13-4A01-90F4-7E160CF98E02Q34988879-3520888F-C6D0-48A0-A327-C61A0B18E8FAQ35047386-F692E840-BDE4-44B6-B87F-70FF781CDEF1Q35135650-B5B009F7-0823-48AF-85EB-58B4DF7A7233Q35610203-7FE0EC89-8566-4B85-9CB9-ABBF554E3E9CQ36616537-91C08AF3-48E7-4328-AE3A-E85FF316819EQ37048013-47C7BF62-8D79-46A2-A0AB-B86484E9E2A8Q37118947-409494D3-F8FF-4FE1-A979-63B38D9B6466Q37955222-17FF6D75-E6E1-408C-8517-2947F610F912Q38961012-290DDF24-D1A1-4C25-B2FB-176986AC8FAEQ45737971-49271A53-7412-4ED2-A85F-3DD578681041Q47882998-881E8452-0C81-4C43-8D25-9BC587948A08Q48037657-CC9D6252-45B1-4EA8-85A3-93CFDB8D1EACQ52981912-C31F291E-3FE9-4630-992B-256D844B5493
P2860
Phase I trial and pharmacokinetics of gemcitabine in children with advanced solid tumors.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Phase I trial and pharmacokinetics of gemcitabine in children with advanced solid tumors.
@en
type
label
Phase I trial and pharmacokinetics of gemcitabine in children with advanced solid tumors.
@en
prefLabel
Phase I trial and pharmacokinetics of gemcitabine in children with advanced solid tumors.
@en
P2093
P356
P1476
Phase I trial and pharmacokinetics of gemcitabine in children with advanced solid tumors.
@en
P2093
Joel M Reid
John Holcenberg
John Kuttesch
Mark D Krailo
Matthew M Ames
Stephanie L Safgren
Wenchun Qu
P304
P356
10.1200/JCO.2004.10.142
P407
P577
2004-06-01T00:00:00Z